Gleyson Francisco da Silva Carvalho

Mr. Gleyson Francisco da Silva Carvalho

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
GCGleyson Francisco da Silva Carvalho
Gleyson Francisco da Silva Carvalho
TCThais Virginia Moura Machado Costa
Thais Virginia Moura Machado Costa
ANAmom Mendes Nascimento
Amom Mendes Nascimento
BWBeatriz Martins Wolff
Beatriz Martins Wolff
JDJulian Gabriel Damasceno
Julian Gabriel Damasceno
LKLeslie Domenici Kulikowski
Leslie Domenici Kulikowski

28 May 2022 in Clinics
Verified
Journal Article
Open access
SCSamar Nasser Chehimi
Samar Nasser Chehimi
VAVanessa Tavares Almeida
Vanessa Tavares Almeida
ANAmom Mendes Nascimento
Amom Mendes Nascimento
ÉZÉvelin Aline Zanardo
Évelin Aline Zanardo
YOYanca Gasparini de Oliveira
Yanca Gasparini de Oliveira
LKLeslie Kulikowski
Leslie Kulikowski
Copy Number Variations (CNVs) in the human genome account for common populational variations but can also be responsible for genetic syndromes depending on the affected region. Although a deletion in 5p is responsible for a syndrome with highly recognizable phenotypical features, other chromosomal abnormalities might overlap phenotypes, especially considering that most studies in 5p use traditional cytogenetic techniques and not molecular techniques. The authors have investigated 29 patients with clinical suspicion of 5p- syndrome using Chromosomal Microarray (CMA), and have gathered information on previous tests, clinical signs, symptoms, and development of the patients. The results showed 23 pure terminal deletions, one interstitial deletion, one deletion followed by a 3 Mb duplication in 5p, three cases of 5p deletion concomitant to duplications larger than 20 Mb in chromosomes 2, 9, and 18, and one 5p deletion with a chromosome Y deletion. CMA showed relevant CNVs not typically associated with 5p- that may have contributed to the final phenotype in these patients. The authors have identified three novel rearrangements between chromosomes 5 and 2 (Patient 27), 5 and 18 (Patient 11), and 5 and Y (Patient 22), with breakpoints and overlapped phenotypes that were not previously described. The authors also highlight the need for further molecular investigation using CMA, in different chromosomes beyond chromosome 5 (since those cases did not show only the typical deletion expected for the 5p- syndrome) to explain discordant chromosomal features and overlapped phenotypes to unravel the cause of the syndrome in atypical cases.

25 November 2024 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
GCGleyson Francisco da Silva Carvalho
Gleyson Francisco da Silva Carvalho
CGClaudio Melo de Gusmão
Claudio Melo de Gusmão
BWBeatriz Martins Wolff
Beatriz Martins Wolff
LVLucas Liro Vieira
Lucas Liro Vieira
YOYanca Gasparini de Oliveira
Yanca Gasparini de Oliveira
LKLeslie Domenici Kulikowski
Leslie Domenici Kulikowski
KMT2B-related dystonia (DYT28, OMIM #617284) is a progressive neurological condition characterized by early onset movement disorders with autosomal dominant inheritance. In this study, we describe the use of a genome methylation episignature methodology to functionally validate two variants of uncertain significance (VUS) in the KMT2B gene. Genome-wide methylation status was assessed using the EPIC methylation assay in peripheral blood samples from two subjects with early onset movement disorder and missense variants of uncertain significance in the KMT2B gene (p.Leu1720Phe and p.Tyr2515Cys). After QC and normalization steps, we compared the M values for all 144 probes, previously described as an EpiSign for KMT2B-related dystonia, between the two subjects and 14 controls individuals. The individual harboring the p.Tyr2515Cys variant exhibited a hypermethylation profile compatible with pathogenic/likely pathogenic variants in KMT2B, allowing for variant reclassification, conclusive genetic counseling, and patient stratification for deep brain stimulation. In contrast, the individual harboring the p.Leu1720Phe variant had a methylation status similar to controls, practically ruling out KMT2B-related dystonia. Investigation of methylation status can be a powerful tool to determine pathogenicity when facing KMT2B variants of uncertain significance. Methylation results may optimize genetic counseling and positively impact patient care.

26 May 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
LWLigia Watanabe
Ligia Watanabe
LSLisete Sousa
Lisete Sousa
FCFrancisco Couto
Francisco Couto
Natalia NoronhaNatalia Noronha
Natalia Noronha
Marcela Augusta de Souza PinhelMarcela Augusta de Souza Pinhel
Marcela Augusta de Souza Pinhel
CNCarla Nonino
Carla Nonino
Blood selenium (Se) concentrations differ substantially by population and could be influenced by genetic variants, increasing Se deficiency-related diseases. We conducted a genome-wide association study (GWAS) to identify single nucleotide polymorphisms (SNPs) associated with serum Se deficiency in 382 adults with admixed ancestry. Genotyping arrays were combined to yield 90,937 SNPs. R packages were applied to quality control and imputation. We also performed the ancestral proportion analysis. The Search Tool for the Retrieval of Interacting Genes was used to interrogate known protein–protein interaction networks (PPIs). Our ancestral proportion analysis estimated 71% of the genome was from Caucasians, 22% was from Africans, and 8% was from East Asians. We identified the SNP rs1561573 in the TraB domain containing 2B (TRABD2B), rs425664 in MAF bZIP transcription factor (MAF), rs10444656 in spermatogenesis-associated 13 (SPATA13), and rs6592284 in heat shock protein nuclear import factor (HIKESHI) genes. The PPI analysis showed functional associations of Se deficiency, thyroid hormone metabolism, NRF2-ARE and the Wnt pathway, and heat stress. Our findings show evidence of a genetic association between Se deficiency and metabolic pathways indirectly linked to Se regulation, reinforcing the complex relationship between Se intake and the endogenous factors affecting the Se requirements for optimal health.

5 March 2024 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MAMárcia Regina Gimenes Adriano
Márcia Regina Gimenes Adriano
ABAdriana Bortolai
Adriana Bortolai
FMFabricia Andreia Rosa Madia
Fabricia Andreia Rosa Madia
GCGleyson Francisco da Silva Carvalho
Gleyson Francisco da Silva Carvalho
ANAmom Mendes Nascimento
Amom Mendes Nascimento
ADAlexandre Torchio Dias
Alexandre Torchio Dias
Objectives: Male infertility accounts for approximately 30% of cases of reproductive failure. The characterization of genetic variants using cytogenomic techniques is essential for the adequate clinical management of these patients. We aimed to conduct a cytogenetic investigation of numerical and structural rearrangements and a genomic study of Y chromosome microdeletions/microduplications in infertile men derived from a single centre with over 14 years of experience. Results: We evaluated 151 infertile men in a transversal study using peripheral blood karyotypes and 15 patients with normal karyotypes through genomic investigation by multiplex ligation-dependent probe amplification (MLPA) or polymerase chain reaction of sequence-tagged sites (PCR-STS) techniques. Out of the 151 patients evaluated by karyotype, 13 presented chromosomal abnormalities: two had numerical alterations, and 11 had structural chromosomal rearrangements. PCR-STS detected a BPY2 gene region and RBMY2DP pseudogene region microdeletion in one patient. MLPA analysis allowed the identification of one patient with CDY2B_1 and CDY2B_2 probe duplications (CDY2B and NLGN4Y genes) and one patient with BPY2_1, BPY2_2, and BPY2_4 probe duplications (PRY and RBMY1J genes).

29 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
BWBeatriz Martins Wolff
Beatriz Martins Wolff
YCYuri Reis Casal
Yuri Reis Casal
LVLucas Liro Vieira
Lucas Liro Vieira
GCGleyson Francisco da Silva Carvalho
Gleyson Francisco da Silva Carvalho
MCMariana Ribeiro Costa
Mariana Ribeiro Costa
LKLeslie Kulikowski
Leslie Kulikowski
Tumor entities of the Central Nervous System (CNS) are defined by the WHO classification and range from benign neoplasms to highly malignant tumors, making histopathological classification challenging. This diverse spectrum complicates clinical decision-making and the interpretation and validation of clinical trial results. The methodology based on DNA methylation profiling of CNS tumors offers greater diagnostic precision compared to traditional morphological methods. In this study, we analyzed 16 DNA samples from medulloblastomas and ependymomas, obtained from paraffin-embedded blocks from the Pathology Division archives of HCFMUSP, and with prior histological analysis. The samples were processed using the Infinium MethylationEPIC BeadChip (Illumina®) and methylation data analysis tools in R Studio. The data were submitted to the MolecularNeuropathology.org platform for methylation based classification and CNV chart generation. The classifier was consistent with the previous diagnosis in all cases, refining the diagnosis in 54% of cases to subclass, 38% to subtype, and 8% to family. The platform also provided CNV estimates for 87% of cases, revealing crucial information on genetic alterations such as gains, losses, amplifications, and gene fusions. Despite the challenges of implementation within the Brazilian Public Health System (SUS), the results demonstrate the method's robustness and reproducibility, promising invaluable support for precise diagnoses and the development of more effective therapeutic strategies.